Posted on 09/05/08
Drop patent regulations, generic drug makers urge
OTTAWA -- Canada's generic drug companies are urging Parliament to abandon proposed regulations that would delay their ability to reproduce some of the most popular name-brand drugs that are currently on the market, including Viagra and Lipitor.
The full text of this article has 589 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
